18-26227129-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005640.3(TAF4B):c.196G>A(p.Val66Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,461,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005640.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF4B | NM_005640.3 | c.196G>A | p.Val66Met | missense_variant | 1/15 | ENST00000269142.10 | NP_005631.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF4B | ENST00000269142.10 | c.196G>A | p.Val66Met | missense_variant | 1/15 | 1 | NM_005640.3 | ENSP00000269142 | P4 | |
TAF4B | ENST00000578121.5 | c.196G>A | p.Val66Met | missense_variant | 1/15 | 2 | ENSP00000462980 | A2 | ||
TAF4B | ENST00000418698.3 | c.196G>A | p.Val66Met | missense_variant, NMD_transcript_variant | 1/16 | 5 | ENSP00000389365 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000406 AC: 1AN: 246104Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134004
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461426Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727024
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2022 | The c.196G>A (p.V66M) alteration is located in exon 1 (coding exon 1) of the TAF4B gene. This alteration results from a G to A substitution at nucleotide position 196, causing the valine (V) at amino acid position 66 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at